期刊文献+

儿童重症肌无力患者胸腺细胞异常增生相关因素分析 被引量:1

Associated Factors of Thymic Hyperplasia in Children with Myasthenia Gravis
下载PDF
导出
摘要 目的探讨儿童重症肌无力(myasthenia gravis,MG)患者胸腺细胞异常增生的机制。方法取单纯胸腺增生型MG患者胸腺组织,经病理组织切片、苏木精-伊红(HE)染色和免疫组化染色,观察患者胸腺组织的结构和分子表达特点;通过提取胸腺组织RNA和基因芯片检查,分析与胸腺异常增生相关的细胞因子、膜分子及信号通路表达。结果 MG患者胸腺细胞显著增生,CD3分子呈强阳性表达,HLA-DR分子在髓质表达更明显。多种细胞因子、膜分子和信号分子表达存在异常,其中BCL2、CCL22、CCL25、CCL3、CCR7、CCR9在儿童MG患者胸腺显著增高;而CCL2、CSF3、CSF3R、CX3CL1、CXCL9、IL-1R、IFNGR2则显著降低。结论儿童MG患者胸腺细胞异常增生与IL-1R、IL-6、IFNGR2、CCL25、CCR9等细胞因子及其受体的异常表达及信号分子BCL2的异常表达有关。 Objective To study the mechanism of thymic hyperplasia in children with myasthenia gravis(MG).Methods The thymus tissues of MG patients with simple thymic hyperplasia were harvested,prepared and subjected to HE staining and immunohistochemical staining.The structure and molecular expression features of the thymus tissues were observed.The expressions of related cytokines,membrane molecules and the signal transduction molecules were measured by total RNA extraction and gene microarray analysis.Results The hyperplasia of thymocytes was obvious in MG patients.The expression of CD3 was strongly positive,and HLA-DR was predominantly expressed in the thymic medulla.A number of cytokines,membrane molecules and signal transduction molecules were found abnormally expressed in MG thymus tissues.The expressions of BCL2,CCL22,CCL25,CCL3,CCR7and CCR9 were dramatically increased in MG thymus,while those of CCL2,CSF3,CSF3R,CX3CL1,CXCL9,IL-1Rand IFNGR2were significantly reduced.Conclusion The thymic hyperplasia in MG children is associated with abnormal expressions of some cytokines(IL-1R,IL-6,IFNGR2,CCL25and CCR9)and signal transduction molecules(BCL2).
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2013年第4期438-441,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.81172874)
关键词 重症肌无力 胸腺细胞 细胞因子 信号转导 myasthenia gravis thymocytes cytokines signal transduction
  • 相关文献

参考文献13

  • 1Nagane Y,Utsugisawa K,Obara D,et al.Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis[J].Muscle Nerve,2003,27(5):582-589.
  • 2Onodera H.The role of the thymus in the pathogenesis of myasthenia gravis[J].Tohoku J Exp Med,2005,207(2):87-98.
  • 3Schwarz B A,Sambandam A,Maillard I,et al.Selective thymus settling regulated by cytokine and chemokine receptors[J].J Immunol,2007,178(4):2008-2017.
  • 4Uehara S,Hayes S M,Li L,et al.Premature expression of chemokine receptor CCR9 impairs T cell development[J].J Immunol,2006,176(1):75-84.
  • 5Le Panse R,Bismuth J,Cizeron-Clairac G,et al.Thymic remodeling associated with hyperplasia in myasthenia gravis[J].Autoimmunity,2010,43(5/6):401-412.
  • 6Scarpino S,Stoppacciaro A,Ballerini F,et al.Papillary carcinoma of the thyroid:hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells[J].Am J Pathol,2000,156(3):831-837.
  • 7Le Panse R,Cizeron-Clairac G,Bismuth J,et al.Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia[J].J Immunol,2006,177(11):7868-7879.
  • 8Scimone M L,Aifantis I,Apostolou I,et al.A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus[J].Proc Natl Acad Sci USA,2006,103(18):7006-7011.
  • 9夏传生,李娜,李明显,李丹.胸苷磷酸化酶及血管内皮生长因子在胃腺癌组织中的表达及其临床意义[J].华中科技大学学报(医学版),2011,40(3):343-346. 被引量:5
  • 10Shiono H,Fujii Y,Okumura M,et al.Failure to down-regulate Bcl-2 protein in thymic germinal center B cells in myasthenia gravis[J].Eur J Immunol,1997,27(4):805-809.

二级参考文献15

  • 1Toi M, Atiqur R M, Bando H, et al. Thymidine phosphorylase (platelet derived endothelial-cell growth factor)in cancer biob ogy and treatment[J]. Lancet Oncol,2005,6(3) : 158-166.
  • 2Shimaoka S,Matsushita S, Nitanda T, et al. The role of thy midine phosphorylase expression in the invasiveness of gastric earcinoma[J]. Cancer, 2000,88 (10) :2220-2227.
  • 3Nishina T, Hyldl I, Miyaike J, et al. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5-deoxy-5-fluoouridine[J]. Eur J Cancer,2004,40(10) :1566-1571.
  • 4Jang J S,Lee W S,Lee J S,et al. The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer[J] J Korean Med Sci, 2007,22 (suppl) : S109- 114.
  • 5Bot F J,Godschalk J C J,Keihuadth K K, et al. Prognostion factors in renal cell carcinoma immunohistochemical detection of P53 protein versus elinicopathaological parameters[J]. int J Cancer, 1994,57(5) : 634-637.
  • 6Liekens S, Bronckaers A, Prez-P6rez M J, et al. Targeting platelet-derived endothelial cell growth facIor/thymidine phosphorylase for cancer therapy [J]. Biochem Pharmacol, 2007,74 ( 11 ) : 1555-1567.
  • 7Akiyama S,Furukawa T,Sumizawa T,et al. The role of thy midine phosphorylase, an angiogenic enzyme, in tumor pro gression[J]. Cancer Sci, 2004,95 ( 11 ) : 851 857.
  • 8Tsujitani S, Saito H, Maeta Y, et ah Neoangiogenesis in pa tients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphoryl ase[J]. Anticancer Res, 2004,24(3b) : 1853-1859.
  • 9Lu H,Klein R S,Schwartz E L. Antiangiogenic and antitumor activity of 6-( 2-aminoethyl ) amino-5 chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in corn bination with the vascular endothelial growth factor-trap[J]. Clin Cancer Res, 2009,15(16) : 5136-5144.
  • 10Uchimiya H, Furukawa T, Okamoto M, et al. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L ribose[J]. Cancer Res, 2002, 62 (10) : 2834-2839.

共引文献4

同被引文献12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部